PI3K/mTOR and topoisomerase inhibitors suggested as candidates to reduce expression of ACE2

PI3K/mTOR and topoisomerase inhibitors suggested as candidates to reduce expression of ACE2

PI3K/mTOR and topoisomerase inhibitors suggested as candidates to reduce expression of ACE2

A recent study published in the preprint server medRxiv in September 2020 shows that the already approved drug families called P13K/mTOR and topoisomerase inhibitors may be useful in reducing individual susceptibility to the virus.